MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
NCT05545098 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 106
Last updated 2022-09-19
Summary
Aim of the work The aim of this study is to compare the role of musculoskeletal ultrasound to serum Survivin and Lubricin in detection of disease activity in patients with oligoarticular and polyarticular juvenile idiopathic arthritis.
Objectives
* To assess disease activity using Juvenile arthritis disease activity score in 27 joints (JADAS 27) in the studied JIA patients.
* To identify the prevalence of functional disability in JIA children and adolescents using the childhood health assessment questionnaire (CHAQ).
* To perform MSUS on the involved joints.
* To assess Survivin in the serum and in the synovial fluid if available in JIA patients.
* To assess Lubricin in the serum and in the synovial fluid if available in JIA patients.
* To compare the disease activity across individual patients using JADAS 27, MSUS and their relation to serum level of Survivin and lubricin.
Conditions
- Juvenile Idiopathic Arthritis
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Mohamed G Mohamed, Ass prof · Assiut University
-
Manal M Ahmed, Ass prof · Assiut University
-
Nagwa A Mohamed, Prof · Assiut University
Eligibility
- Min Age
- 2 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-30
- Primary Completion
- 2024-05-31
- Completion
- 2024-08-31
More Related Trials
-
ARTEMIS Synovial Markers in Arthritis Childhood
NCT02505828 ·Status: COMPLETED ·Phase: NA
-
Targeting Synovitis in Early Rheumatoid Arthritis
NCT00920478 ·Status: UNKNOWN ·Phase: PHASE4
-
Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study
NCT01659242 ·Status: TERMINATED ·Phase: PHASE4
-
Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
NCT01299961 ·Status: COMPLETED ·Phase: PHASE3
-
Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population
NCT01782469 ·Status: TERMINATED
-
Empowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology
NCT02205086 ·Status: UNKNOWN ·Phase: NA
-
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513 ·Status: NOT_YET_RECRUITING
-
Indications and Interest of US-guided Synovial Biopsies Performed in Clinical Practice
NCT03417167 ·Status: COMPLETED
-
Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]
NCT01145352 ·Status: COMPLETED
-
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
NCT00001679 ·Status: COMPLETED
-
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
NCT05534347 ·Status: RECRUITING
-
Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
NCT02024334 ·Status: UNKNOWN ·Phase: PHASE4
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
Is Ultrasound Remission a Real Remission? Does Ultrasound Permit to Achieve and Maintain the Remission in Rheumatoid Arthritis Patients More Efficiently Than Clinical Scores?
NCT02140229 ·Status: UNKNOWN ·Phase: NA
-
JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis)
NCT04084223 ·Status: TERMINATED ·Phase: NA
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Survivin as Predictive Biomarker for RA
NCT03444623 ·Status: UNKNOWN
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
NCT01602302 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
NCT00652925 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis
NCT01787149 ·Status: UNKNOWN ·Phase: PHASE3
-
Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment
NCT00902005 ·Status: COMPLETED
-
A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis
NCT01298531 ·Status: COMPLETED ·Phase: PHASE4
-
Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab
NCT01717859 ·Status: COMPLETED ·Phase: PHASE4
-
Juvenile Arthritis Quantitative Imaging
NCT02684695 ·Status: RECRUITING